French pharmaceutical giant Sanofi SA yesterday said it suffered a loss in the second quarter after it booked nearly 3 billion euros (US$3.34 billion) in write-downs of the value of its assets, but said it remained confident that net profit would rise for the year.
The net loss of 87 million euros came despite a 5.5 percent increase in net sales to 8.6 billion euros, which was slightly higher than the analyst consensus compiled by financial data firm FactSet Research Systems Inc.
The company pointed to a more than 20 percent jump in sales at Sanofi Genzyme, its bio-tech specialty care firm that it created following its 2011 acquisition of Genzyme Corp for 15 billion euros, thanks to a strong launch of Dupixent, a treatment for atopic dermatitis and asthma.
Gross profit rose by 7.6 percent in the first half to 12.3 billion euros, but write-downs to the value of its assets and restructuring charges weighed in at more than 3.7 billion euros.
Included in that was a 1.8 billion euro charge against hemophilia treatment Eloctate due to disappointing sales in the US, which fell by 11 percent on a comparative basis.
Nevertheless, chief executive Olivier Brandicourt said: “We are confident in the growth outlook for the year.”
The firm revised upward its forecast for full-year earnings per share to an increase of US$0.05 per share.
Sanofi shares advanced 2.3 percent after it raised its outlook for this year on the back of strong growth in its vaccines and rare diseases businesses.
PRESSURE FROM THE US: Huawei said a decision by the US was ‘arbitrary and pernicious, and threatens to undermine the entire [technology] industry worldwide’ Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) has stopped new orders from Huawei Technologies Co (華為) in response to Washington’s move aimed at further limiting chip supplies to the Chinese company, the Nikkei reported yesterday, citing multiple sources. The orders that TSMC took before the new ban and those that were already in production are not affected, and could continue to proceed if those chips could be shipped before the middle of September, the report said. TSMC, the world’s biggest contract chipmaker and a key Huawei supplier, on Thursday last week announced plans to build a US-based plant and on Friday added that
MediaTek Inc (聯發科), which designs chips used in mobile phones, yesterday launched its new 5G Dimensity 820 system-on-chip (SoC), targeting mid-range to high-end smartphones. The company expects the penetration of 5G technology to gain pace quickly this year and not be affected too much by the COVID-19 pandemic. MediaTek said it aims to expand its 5G chip portfolio this year to cover phones of varying prices after it shipped its first 5G SoC, the Dimensity 1000, last quarter. The Dimensity 820, made by Taiwan Semiconductor Manufacturing Co (台積電) on 7-nanometer technology, is designed for mid-range to high-end 5G phones. MediaTek expects to infiltrate the
TV and online retailer Momo.com Inc (富邦媒體) yesterday said it has set up a new logistics subsidiary, Fu Sheng Logistics Co (富昇物流), to oversee the company’s extensive shipping operations. Leveraging Momo’s 23 satellite warehouses and distribution centers nationwide, Fu Sheng will be in charge of executing the retailer’s same-day shipment plan for deliveries in Taipei, New Taipei City, Taoyuan, Taichung, Tainan and Kaohsiung, Momo said in a press release. Seeking to further shorten its supply chain, the company is to set up another seven satellite warehouses and distribution centers by the end of the year. “Fu Sheng has a fleet of 200 couriers
US-CHINA TENSIONS: The company said that it supplies self-designed chips to the Chinese company and, as such, is not affected by the latest US export restrictions Macronix International Co (旺宏電子) said it does not expect its shipments of memory chips to Huawei Technologies Co (華為) to be affected by the latest US export restrictions on the Chinese tech giant. “As long as the company [Huawei] places orders, we will ship [chips], unless the [Taiwanese] government restricts all Taiwanese companies from shipping” to Huawei, Macronix chairman and chief executive officer Miin Wu (吳敏求) said on Monday in Hsinchu. The US Department of Commerce on Friday took a further step to block chip supplies from non-US companies to Huawei by requiring foreign semiconductor makers to get US government permission before